During the past decade, Translational Research Institute for Metabolism and Diabetes conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 6 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Translational Research Institute for Metabolism and Diabetes" #1 sponsor was "AdventHealth Translational Research Institute" with 43 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Translational Research Institute for Metabolism and Diabetes" #1 collaborator was "Sanford-Burnham Medical Research Institute" with 8 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "AdventHealth" with 1 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator and "Arizona State University" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Translational Research Institute for Metabolism and Diabetes" are "Obesity" (13 trials), "Diabetes" (7 trials), "Type 2 Diabetes" (6 trials), "Metabolic Diseases" (3 trials) and "Sarcopenia" (3 trials). Many other conditions were trialed in "Translational Research Institute for Metabolism and Diabetes" in a lesser frequency.

Most popular intervention types in "Translational Research Institute for Metabolism and Diabetes" are "Other" (21 trials), "Procedure" (13 trials), "Drug" (12 trials), "Behavioral" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Exercise" (3 trials), "Glucagon" (3 trials), "Adipose Tissue Biopsy" (2 trials) and "DEXA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Translational Research Institute for Metabolism and Diabetes" are 45 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Translational Research Institute for Metabolism and Diabetes". 1 are not yet recruiting, 13 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Translational Research Institute for Metabolism and Diabetes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Translational Research Institute for Metabolism and Diabetes, 8 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".